The mammalian target of rapamycin (mTOR) emerged as a critical pathway driving tumor growth by promoting the synthesis of new blood vessels and over-expression of proteins that control the progression of cell through the cell cycle, cyclins. The gene discussed is MTOR; the disease is neoplasm.